Ticagrelor
NDC 72516-017, Ticagrelor, tablet, from Oryza Pharmaceuticals, Inc..
- Product NDC
- 72516-017
- Status
- Listed
- Labeler
- Oryza Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208508
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72516-017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TICAGRELOR60 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P-Glycoprotein Inhibitors [MoA]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72516-017-06 | 72516001706 | 60 TABLET in 1 BOTTLE (72516-017-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/461d810e-5b77-5e53-e063-6294a90a64b0NADAC price for package 72516001706
GET /v1/drugs/nadac/72516001706
Use it
Look up 72516-017 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72516-017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72516-017. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.